BREAKING
Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 11 minutes ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 52 minutes ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 4 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 4 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 5 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 5 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 5 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 11 minutes ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 52 minutes ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 4 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 4 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 5 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 5 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 5 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago
ADVERTISEMENT

Earnings: Dentsply Sirona Q4 profit beats despite revenue drop; stock jumps

Dentsply Sirona (XRAY), a provider of dental products and technology, reported a decline in earnings and revenues for the fourth quarter of 2018. However, the results exceeded the consensus analysts’ estimate, driving the stock higher on Friday. At $1.06 billion, net sales were down 2.9% from the prior-year quarter. The top-line came in slightly above […]

March 1, 2019 2 min read

Dentsply Sirona (XRAY), a provider of dental products and technology, reported a decline in earnings and revenues for the fourth quarter of 2018. However, the results exceeded the consensus analysts’ estimate, driving the stock higher on Friday.

An infographic on DENTSPLY SIRONA's fourth quarter 2018 earnings results
DENTSPLY SIRONA Q4 2018 Earnings Infographic

At $1.06 billion, net sales were down 2.9% from the prior-year quarter. The top-line came in slightly above the forecast. A 4.6% revenue growth in Europe and a 1.4% gain in rest of the world were eclipsed by a 14.7% contraction in the US amid hectic destocking by dealers.

Among the product categories, Consumable revenue rose 3.4% annually, helped by the recent recovery in shipments at the company’s European distribution center. Meanwhile, Technology & Equipment revenue fell by 7.4%.

Consumable revenue rose 3.4% annually, helped by the recent recovery in shipments at the European distribution center

Adjusted earnings dropped to $0.58 per share during the three-month period from $0.82 per share in the fourth quarter of 2017. Reported profit was $1.8 million or $0.01 per share, compared to a loss of $650.4 million or $2.85 share in the year-ago quarter.

Related: Dentsply Q3 2018 Earnings Conference Call Transcript

ADVERTISEMENT

“We have completed a top to bottom diagnostic of the Company and are executing a major restructuring plan to accelerate growth, improve margins and simplify our business,” said CEO Don Casey.

For fiscal 2019, the management expects adjusted earnings in the range of $2.25 per share to $2.40 per share, which represents a 12-19% annual growth. The forecast for full-year reported revenue is $3.95-$4.05 billion. The top line will be negatively impacted by the ongoing portfolio shaping initiatives and unfavorable exchange rates.

Also read: Johnson & Johnson buys Auris Health

Internal sales are estimated to grow between 4% and 5% this year, benefitting from new product launches and the absence of dealer destocking. Going forward, the efforts to simplify the organizational structure, such as consolidation of the dental product groups and regional commercial groups, are expected to strengthen performance.

Shares of Dentsply surged about 8% in the pre-market hours Friday following the earnings report, after closing the previous session higher. Since the beginning of 2019, the stock gained more than 10%.

ADVERTISEMENT

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

ADVERTISEMENT